Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

589
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
589
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

597
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
597
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

464
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
464
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

3.3K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.3K
Asthma-I: Introduction01:29

Asthma-I: Introduction

2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From Tregs to tissue remodelling: FOXP3 and IL-35 in the inflammatory landscape of nasal polyps.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2026
Same author

Availability and Costs of Allergic Rhinitis Treatments Across the World: A Survey of ARIA Experts.

Allergy·2026
Same author

Botulinum toxin for allergic rhinitis: a systematic review and meta-analysis of its therapeutic potential.

Current opinion in allergy and clinical immunology·2026
Same author

Biologics for chronic rhinosinusitis with nasal polyps: from downstream cytokine blockade to upstream epithelial targets.

Current opinion in allergy and clinical immunology·2026
Same author

Heat generation and thermal safety of powered instrumentation in endoscopic sinus surgery.

Current opinion in allergy and clinical immunology·2026
Same author

Effect of platelet-rich plasma on surgical outcomes in chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis.

Current opinion in allergy and clinical immunology·2026

Related Experiment Video

Updated: Sep 14, 2025

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

674

Moving Towards an Integrated Approach to Allergic Rhinitis Management: ARIA and EUFOREA Guidelines Similarities and

Désirée E S Larenas-Linnemann1, Lawrence Chun-Wei Loy2, Baharudin Abdullah3

  • 1Center of Excellence in Asthma and Allergy, Hospital Médica Sur, Puente de Piedra 150, T2-602; Colonia Toriello-Guerra, Delegación Tlalpan, Mexico City, 14050, Mexico. marlar1@prodigy.net.mx.

Current Allergy and Asthma Reports
|July 23, 2025
PubMed
Summary

This review compares Allergic Rhinitis and its Impact on Asthma (ARIA) and EUFOREA guidelines for allergic rhinitis (AR) management. Awareness of these guidelines can improve personalized care and patient outcomes.

Keywords:
ARIAAdherenceAllergic rhinitisEUFOREAGuidelinesIntranasal corticosteroid

More Related Videos

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.5K
Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
06:08

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Published on: September 22, 2023

1.9K

Related Experiment Videos

Last Updated: Sep 14, 2025

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

674
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.5K
Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
06:08

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Published on: September 22, 2023

1.9K

Area of Science:

  • Allergy and immunology
  • Respiratory medicine
  • Digital health

Background:

  • Allergic rhinitis (AR) significantly impacts asthma and patient quality of life.
  • Current management guidelines aim for personalized and patient-centered care.
  • The Allergic Rhinitis and its Impact on Asthma (ARIA) and European Forum for Research and Education in Allergy and Airway Disease (EUFOREA) guidelines offer evidence-based approaches.

Purpose of the Study:

  • To provide a side-by-side comparison of key elements from ARIA and EUFOREA guidelines.
  • To highlight the evolution of AR guidelines towards precision medicine and enhanced doctor-patient partnerships.
  • To raise awareness of these crucial guidelines for allergic rhinitis management.

Main Methods:

  • Comparative review of ARIA and EUFOREA guideline content.
  • Analysis of guideline evolution, focusing on personalization and digital integration.
  • Identification of barriers to real-world implementation and potential solutions.

Main Results:

  • Both ARIA and EUFOREA provide evidence-based guidance for AR management, emphasizing personalization and digital tools.
  • Key differences exist in patient classification, treatment delivery, and implementation strategies.
  • Barriers to implementation include the need for adaptation, education, and better alignment with patient behavior.

Conclusions:

  • Increased awareness and understanding of ARIA and EUFOREA guidelines can harmonize treatment.
  • Addressing implementation barriers is crucial for effective guideline adoption.
  • Leveraging digital health tools and fostering stronger doctor-patient relationships can enhance AR care and outcomes.